ResMed CEO On Earnings, Sleep Apnea

ResMed (RMD) CEO Mick Farrell joins Morning Trade Live to discuss the company’s latest earnings beat. ResMed primarily focuses on sleep apnea and COPD. He talks about GLP-1 medications and consumer tech offering medical monitoring like the Apple (AAPL) Watch. He discusses the customer base for ResMed and its hardware vs software businesses.

Morning Trade Live

29 Oct 2024

SHARE

Schwab Network's Newsletters

Daily insights for every investor

ON AIR
5:00 pm
Next Gen Investing
replay
12:00 am
The Wrap
REPLAY
12:30 am
Market On Close
REPLAY
2:00 am
Trading 360
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
5:00 am
Market Overtime
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Morning Movers
8:00 am
Opening Bell With Nicole Petallides
9:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Fast Market
REPLAY
ON AIR
5:00 pm
Next Gen Investing
REPLAY
6:00 pm
The Wrap
REPLAY
7:30 pm
Market Overtime
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market On Close
REPLAY
10:00 pm
Trading 360
REPLAY
11:00 pm
The Wrap
REPLAY